Categories
Health

What to Know About Boosters if You Obtained the Johnson & Johnson Vaccine

Without robust data on the long-term effectiveness of the Johnson & Johnson vaccine, it is difficult for health officials to recommend booster vaccinations, said John Moore, a virologist at Weill Cornell Medicine. “If you are making data-driven decisions and you don’t have the data, what can you do?” He said. “It’s kind of a dilemma. Public trust in vaccines generally depends on how the sausage is made, as it is a data-driven, transparent process. “

Clinical studies conducted prior to the distribution of the Delta variant found that the Johnson & Johnson vaccine was 72 percent overall effective in the United States, less than the approximately 95 percent effectiveness of the Pfizer and Moderna vaccines. However, direct comparisons between vaccines tested in different places and at different times are difficult.

All available vaccines seem to be becoming less effective against Delta, which may evade some antibodies of the immune system. The Johnson & Johnson vaccine is no exception. “You would expect there to be some resistance to Delta because there always is,” said Dr. Moors.

Small laboratory studies have produced conflicting results about how well the Johnson & Johnson vaccine protects against Delta. Last month, Johnson & Johnson said a single dose of its vaccine produced a strong immune response against Delta and that the reaction lasted for at least eight months.

Updated

Aug. 20, 2021, 8:20 p.m. ET

But data from another recent laboratory study suggested that a single dose of the vaccine produced a relatively weak antibody response to Delta, which could make boosters more important.

The first real data on the vaccine’s effectiveness against the variant were released this month. The data, which are preliminary results from a clinical study of nearly 500,000 healthcare workers in South Africa, suggest that a single dose of the vaccine has an effectiveness of up to 96 percent against deaths and 71 percent against hospitalizations due to infection Delta had.

It was “a very extensive analysis and very clear results that showed that the single-shot J. & J. Vaccine provided significant protection against the Delta variant, ”said Dr. Dan Barouch, a virologist at Beth Israel Deaconess Medical Center in Boston who conducted studies for Johnson & Johnson but was not involved in the South Africa study.

Categories
Politics

U.S. to Advise Boosters for Most Individuals eight Months After Vaccination

WASHINGTON – The Biden government has decided that most Americans should have a coronavirus booster vaccination eight months after receiving their second vaccination and could start offering third vaccinations as early as mid-September, according to administrative officials familiar with the discussions.

Officials want to announce the decision later this week. Their goal is to let Americans who have received the Pfizer BioNTech or Moderna vaccines know now that they need additional protection against the Delta variant, which is causing case numbers to rise across much of the country. The new policy is subject to approval of additional syringes from the Food and Drug Administration.

Officials said they expect recipients of the Johnson & Johnson vaccine, which has been approved as a one-dose regimen, will also need an additional dose. But they are waiting for the results of the two-dose clinical trial from this company, which is expected later this month.

The first boosters should go to nursing home residents, health workers and rescue workers. They would likely be followed by other elderly people who were on the front lines at the start of vaccinations late last year, then the general population. Officials envision giving people the same vaccine they were originally given.

The decision is made as the Biden government struggles to regain control of a pandemic it allegedly tamed a little over a month ago. President Biden had declared the nation reopened to normal life for the July 4th holiday, but the spread of the Delta Variant wildfires has thwarted this. Covid-19 patients are again overwhelming hospitals in some states, and federal officials are concerned about an increase in the number of children being hospitalized at the beginning of the school year.

For weeks, officials in the Biden administration have been analyzing the rise in Covid-19 cases, trying to find out whether the Delta variant is better able to avoid vaccines or whether the vaccines have lost strength over time. According to some administrative experts, either could be true, a worrying combination that is resurrecting a pandemic the nation fervently hoped has been contained.

Dr. Francis S. Collins, director of the National Institutes of Health, told Fox News Sunday that “there is concern that the vaccine may wear off.” That, combined with the ferocity of the Delta variant, could dictate boosters, he said.

Federal health officials were particularly concerned about data from Israel suggesting the Pfizer BioNTech vaccine’s protection against serious illness has fallen significantly in older people who received their second vaccination in January or February.

Israel can in some ways be seen as a role model for the United States, having vaccinated a larger portion of its population faster and using almost exclusively the Pfizer BioNTech vaccine, which made up much of the US population. Unlike the United States, however, Israel has a nationalized health system that allows patients to be systematically tracked.

The latest Israeli data, released Monday on the government’s website, shows what some experts consider to be the ongoing erosion of the Pfizer vaccine’s effectiveness against mild or asymptomatic Covid-19 infections in general and against serious illnesses in the elderly who vaccinated early, have described the year.

Updated

Aug. 16, 2021, 10:32 p.m. ET

One slide suggests that for those over 65 who received their second vaccination in January, the vaccine is only about 55 percent effective against serious illnesses. However, the researchers found that the data had a large margin of error, and some said that other Israeli government data suggested that the decline in effectiveness was less severe.

“It’s showing a pretty big drop in effectiveness against infections, but it’s still a little unclear about protection against serious diseases,” said Dr. Peter J. Hotez, a vaccines expert at Baylor College of Medicine in Houston, who contributed the data. checked the New York Times request.

Dr. Jesse L. Goodman, a former chief scientist with the Food and Drug Administration who also reviewed the data, said this indicates “worrying trends” that could signal a decline in vaccine effectiveness. But he said he would like to see more details about Israel and, more importantly, data that shows whether the United States is going in the same direction.

Understand the state of vaccination and masking requirements in the United States

    • Mask rules. The Centers for Disease Control and Prevention in July recommended that all Americans, regardless of vaccination status, wear masks in public places indoors in areas with outbreaks, reversing the guidelines offered in May. See where the CDC guidelines would apply and where states have implemented their own mask guidelines. The battle over masks is controversial in some states, with some local leaders defying state bans.
    • Vaccination regulations. . . and B.Factories. Private companies are increasingly demanding corona vaccines for employees with different approaches. Such mandates are legally permissible and have been confirmed in legal challenges.
    • College and Universities. More than 400 colleges and universities require a vaccination against Covid-19. Almost all of them are in states that voted for President Biden.
    • schools. On August 11, California announced that teachers and staff at both public and private schools would have to get vaccinated or have regular tests, the first state in the nation to do so. A survey published in August found that many American parents of school-age children are against mandatory vaccines for students but are more likely to support masking requirements for students, teachers and staff who are not vaccinated.
    • Hospitals and medical centers. Many hospitals and large health systems require their employees to have a Covid-19 vaccine, due to rising case numbers due to the Delta variant and persistently low vaccination rates in their communities, even within their workforce.
    • new York. On August 3, New York City Mayor Bill de Blasio announced that workers and customers would be required to provide proof of vaccination when dining indoors, gyms, performances, and other indoor situations. City hospital staff must also be vaccinated or have weekly tests. Similar rules apply to employees in New York State.
    • At the federal level. The Pentagon announced that it would make coronavirus vaccinations compulsory for the country’s 1.3 million active soldiers “by mid-September at the latest. President Biden announced that all civil federal employees would need to be vaccinated against the coronavirus or undergo regular tests, social distancing, mask requirements and travel restrictions.

Federal officials said the booster program will most likely follow the same scenario as the initial vaccination program. The first syringes for the general public in the United States were given on December 14, days after the FDA approved the Pfizer emergency shot. A week later, people received the Moderna vaccine.

While frontline health workers and nursing home residents were among the first to be vaccinated nationwide, states had their own plans for who else would be vaccinated during the first weeks and months of the vaccination campaign.

But almost everyone over 65 will have qualified for a vaccination by the end of February, as have many police officers, teachers, grocery store workers, and others exposed to the virus in the workplace.

The regulatory path for additional recordings is not entirely clear. Pfizer-BioNTech filed data with the FDA on Monday demonstrating the safety and effectiveness of a booster vaccination. But the data was preliminary, from a phase 1 clinical trial. Moderna is following a similar path, studying the safety and effectiveness of both half and full doses as a third shot.

The World Health Organization has called for a moratorium on booster vaccinations until the end of September, stating that the doses available should be used to help countries lagging far behind on vaccinations. But Israel is already offering third recordings to those who are at least 50 years old. Germany and France have announced that they will offer additional vaccinations to vulnerable populations next month. Britain has a plan to do so, but is holding back for the time being.

Late last week, the FDA approved third doses of the Pfizer and Moderna vaccines for certain people with compromised immune systems, and the Centers for Disease Control and Prevention recommended them. Authorities decided that these people, who make up less than 3 percent of Americans, deserve extra shots as many do not respond to the standard dose. The agency has not yet approved any of the vaccines for children under the age of 12.

Noah Weiland contributed the reporting.

Categories
Health

Not prudent to deploy vaccine boosters at this level: Ex-FDA director

There is currently insufficient evidence that Covid vaccine booster shots are required, according to a former FDA director.

“It is a good thing to be prepared to make boosters, but we really don’t have … evidence, at least in the United States, where we’re seeing vaccine failures or a decrease in immunity, so it’s time to put a booster on “said Norman Baylor, who previously worked for the US Food and Drug Administration’s Vaccine Research and Review Bureau.

Pharmaceutical company Pfizer is developing a Covid booster, or third dose, to combat the highly transmissible Delta variant, which has become the dominant strain in many countries, including the United States

The Centers for Disease Control and Prevention and the FDA said in a joint statement last week that “Americans who have been fully vaccinated currently do not need a booster dose”.

Pfizer met with U.S. officials Monday to plead for a third shot.

The company worked with German company BioNTech to develop a vaccine consisting of two doses given three weeks apart. In December it received emergency approval from the World Health Organization.

No significant vaccination failure

The vaccine errors are currently very small with the vaccines currently in use. Until that changes, I don’t think it would be advisable to give a booster dose.

Norman Baylor

CEO of Biologics Consulting

Westbury, NY: A man receives the Moderna COVID-19 vaccine while at the Long Island State Qualified Health Center in Westbury, New York on April 29, 2021. (Photo by Steve Pfost / Newsday via Getty Images)

Steve Pfost | News day | Getty Images

He said health officials seem to agree that a third dose is not required.

“We’re just not there yet … we have no evidence that it is time to get a booster,” he said, adding that there may be new variations in the future that make current vaccines ineffective or much less effective.

Vaccination inequality

Richer countries have been able to vaccinate a large part of their population, while poorer countries lag behind.

The issue of vaccine disparity between regions needs to be addressed, Baylor said.

“A pandemic itself, the definition is that it is global,” he said, adding that he agreed with the World Health Organization that the crisis must be viewed from a global perspective.

Some countries and regions are actually ordering millions of booster doses before other countries have had supplies to vaccinate their health workers and those most at risk.

Tedros Adhanom Ghebreyesus

Director General, World Health Organization

WHO director general Tedros Adhanom Ghebreyesus said Monday the world is “in the midst of a growing two-pronged pandemic”.

“Some countries and regions are actually ordering millions of booster doses before other countries have had supplies to vaccinate their health workers and the most vulnerable,” he said during a press conference, adding that the world Make “conscious choices” so as not to protect those most in need.

The data suggest the vaccines offer long-lasting immunity to severe and deadly Covid-19, he said.

“The priority now must be to vaccinate those who have received no doses and no protection,” said the WHO chief.

Biotech companies such as Pfizer-BioNTech and Moderna, which have developed another mRNA vaccine against Covid-19, must “give everything” to direct supply to the places in need, including through the Covax vaccine distribution alliance, he added.

Categories
Politics

U.S. to Purchase 200 million Extra Moderna Photographs, In Case Boosters Are Wanted

The Biden government, which is planning the possibility of Americans needing booster shots of the coronavirus vaccine, has agreed to purchase an additional 200 million doses from drug maker Moderna, with the option to include all anti-variant and pediatric doses.

The purchase, which shipments are expected to begin this fall and continue next year, gives the administration the flexibility to use booster shots if necessary and vaccinate children under 12 if the Food and Drug Administration approves vaccination for that age group at two Administrative officials who are not empowered to discuss it publicly.

Experts don’t know yet whether or when booster shots might be required. The emergence of variants in recent months has sped research on boosters, and current vaccines are believed to be effective against several variants, including the alpha variant, which was first identified in the UK and became dominant in the United States.

And this week, US health officials classified the Delta variant, first found in India, as a “worrying variant” and raised the alarm because it is spreading rapidly and can cause more severe illness in unvaccinated people. Concerns about Delta caused England to postpone lifting the pandemic restrictions.

Moderna, a company that had no products on the market until the FDA granted emergency approval for the Covid vaccine last year, uses mRNA platform technology to manufacture its vaccine – a so-called “plug and play” – Method that can be particularly adapted to the reformulation. Last month, the company announced preliminary data from a clinical trial of a booster vaccine matched to the beta variant first identified in South Africa; The study found an increased antibody response to beta and gamma, another worrying variant first identified in Brazil.

Announcing the purchase on Wednesday, Moderna said it is expected to ship 110 million of the new cans in the fourth quarter of this year and 90 million in the first quarter of 2022. The option brings all of Moderna’s US procurement of two-shot vaccine up to 500 million doses.

“We appreciate working with the US government on these extra doses of the Moderna Covid-19 vaccine, which could be used as a primary vaccination, including for children, or possibly as a booster dose if necessary to further defeat the pandemic . ”That said Stéphane Bancel, CEO of Moderna.

“We continue to focus on being proactive in the development of the virus, using the flexibility of our mRNA platform to stay one step ahead of emerging variants,” he said.

Under its existing contract with Moderna, the federal government had until Tuesday to exercise the option to purchase doses for future vaccination needs at the same price it currently pays – about $ 16.50 per dose. Similar discussions are ongoing with Pfizer-BioNTech, which also makes a two-dose mRNA vaccine, but no agreement was reached, one of the officials said.

The state health authorities are also preparing for the need for “re-vaccination,” said Dr. Nirav Shah, president of the Association of State and Territorial Health Officials and Maine’s chief health officer, told reporters on Wednesday.

“It may be a little early to be able to say definitively whether second doses or booster doses will be needed in the fall,” said Dr. Shah. “The better work we’re doing now certainly reduces the likelihood that variants could run free.”

He added, “There is a direct link between what we are doing now and what we may need to do later.”

According to the federal government, about 65 percent of US adults had received at least one injection by Wednesday. However, as vaccination rates slow, the government is still focused on meeting President Biden’s goal of getting at least 70 percent of adults vaccinated by July 4th, and also on addressing the global vaccine shortage.

“As the Delta variant in question grows and millions more Americans need to be vaccinated, we are focused on our urgent and robust response to the pandemic,” White House spokesman Kevin Munoz said in a statement Tuesday.

Last week, at the start of his meeting with the leaders of the Group of 7 Nations, Mr Biden announced that the United States would buy 500 million doses of Pfizer vaccine and donate them to about 100 low and middle income countries for use the next Year, describing it as America’s “humanitarian obligation to save as many lives as possible.”

One of the officials said Wednesday that the government would donate these doses to other countries if the purchase of Moderna left the administration with excess vaccine.